REPORT ID 3851

Asia-Pacific Rivaroxaban Market Report 2017

Publish Date
14-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the Asia-Pacific Rivaroxaban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Rivaroxaban for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Rivaroxaban market competition by top manufacturers/players, with Rivaroxaban sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer
    J&J
    ...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    2.5 mg
    10 mg
    15 mg
    20 mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Rivaroxaban for each application, includin
    Acute coronary syndrome (ACS)
    Venous thromboembolism (VTE)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Rivaroxaban Market Report 2017
1 Rivaroxaban Overview
    1.1 Product Overview and Scope of Rivaroxaban
    1.2 Classification of Rivaroxaban by Product Category
        1.2.1 Asia-Pacific Rivaroxaban Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Rivaroxaban Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 2.5 mg
        1.2.4 10 mg
        1.2.5 15 mg
        1.2.6 20 mg
    1.3 Asia-Pacific Rivaroxaban Market by Application/End Users
        1.3.1 Asia-Pacific Rivaroxaban Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Acute coronary syndrome (ACS)
        1.3.3 Venous thromboembolism (VTE)
    1.4 Asia-Pacific Rivaroxaban Market by Region
        1.4.1 Asia-Pacific Rivaroxaban Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Rivaroxaban (2012-2022)
        1.5.1 Asia-Pacific Rivaroxaban Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Rivaroxaban Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Rivaroxaban Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Rivaroxaban Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Rivaroxaban Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Rivaroxaban Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Rivaroxaban (Volume and Value) by Type
        2.2.1 Asia-Pacific Rivaroxaban Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Rivaroxaban Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Rivaroxaban (Volume) by Application
    2.4 Asia-Pacific Rivaroxaban (Volume and Value) by Region
        2.4.1 Asia-Pacific Rivaroxaban Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Rivaroxaban Revenue and Market Share by Region (2012-2017)

3 China Rivaroxaban (Volume, Value and Sales Price)
    3.1 China Rivaroxaban Sales and Value (2012-2017)
        3.1.1 China Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Rivaroxaban Revenue and Growth Rate (2012-2017)
        3.1.3 China Rivaroxaban Sales Price Trend (2012-2017)
    3.2 China Rivaroxaban Sales Volume and Market Share by Type
    3.3 China Rivaroxaban Sales Volume and Market Share by Application

4 Japan Rivaroxaban (Volume, Value and Sales Price)
    4.1 Japan Rivaroxaban Sales and Value (2012-2017)
        4.1.1 Japan Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Rivaroxaban Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Rivaroxaban Sales Price Trend (2012-2017)
    4.2 Japan Rivaroxaban Sales Volume and Market Share by Type
    4.3 Japan Rivaroxaban Sales Volume and Market Share by Application

5 South Korea Rivaroxaban (Volume, Value and Sales Price)
    5.1 South Korea Rivaroxaban Sales and Value (2012-2017)
        5.1.1 South Korea Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Rivaroxaban Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Rivaroxaban Sales Price Trend (2012-2017)
    5.2 South Korea Rivaroxaban Sales Volume and Market Share by Type
    5.3 South Korea Rivaroxaban Sales Volume and Market Share by Application

6 Taiwan Rivaroxaban (Volume, Value and Sales Price)
    6.1 Taiwan Rivaroxaban Sales and Value (2012-2017)
        6.1.1 Taiwan Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Rivaroxaban Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Rivaroxaban Sales Price Trend (2012-2017)
    6.2 Taiwan Rivaroxaban Sales Volume and Market Share by Type
    6.3 Taiwan Rivaroxaban Sales Volume and Market Share by Application

7 India Rivaroxaban (Volume, Value and Sales Price)
    7.1 India Rivaroxaban Sales and Value (2012-2017)
        7.1.1 India Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Rivaroxaban Revenue and Growth Rate (2012-2017)
        7.1.3 India Rivaroxaban Sales Price Trend (2012-2017)
    7.2 India Rivaroxaban Sales Volume and Market Share by Type
    7.3 India Rivaroxaban Sales Volume and Market Share by Application

8 Southeast Asia Rivaroxaban (Volume, Value and Sales Price)
    8.1 Southeast Asia Rivaroxaban Sales and Value (2012-2017)
        8.1.1 Southeast Asia Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Rivaroxaban Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Rivaroxaban Sales Price Trend (2012-2017)
    8.2 Southeast Asia Rivaroxaban Sales Volume and Market Share by Type
    8.3 Southeast Asia Rivaroxaban Sales Volume and Market Share by Application

9 Australia Rivaroxaban (Volume, Value and Sales Price)
    9.1 Australia Rivaroxaban Sales and Value (2012-2017)
        9.1.1 Australia Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Rivaroxaban Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Rivaroxaban Sales Price Trend (2012-2017)
    9.2 Australia Rivaroxaban Sales Volume and Market Share by Type
    9.3 Australia Rivaroxaban Sales Volume and Market Share by Application

10 Asia-Pacific Rivaroxaban Players/Suppliers Profiles and Sales Data
    10.1 Bayer
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Rivaroxaban Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 J&J
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Rivaroxaban Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    ...

11 Rivaroxaban Manufacturing Cost Analysis
    11.1 Rivaroxaban Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Rivaroxaban

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Rivaroxaban Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Rivaroxaban Market Forecast (2017-2022)
    15.1 Asia-Pacific Rivaroxaban Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Rivaroxaban Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Rivaroxaban Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Rivaroxaban Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Rivaroxaban Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Rivaroxaban Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Rivaroxaban Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Rivaroxaban Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Rivaroxaban Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Rivaroxaban Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Rivaroxaban Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Rivaroxaban Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Rivaroxaban Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Rivaroxaban Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Rivaroxaban Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Rivaroxaban Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Rivaroxaban Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Rivaroxaban Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Rivaroxaban Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer